Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: Characteristics, outcomes, and prognostication among a large multicenter cohort-Reference-Cited by-同舟云学术

Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: Characteristics, outcomes, and prognostication among a large multicenter cohort

Published:2015-08-21 Issue:9 Volume:90 Page:778-783
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Evens Andrew M.¹,Kanakry Jennifer A.²,Sehn Laurie H.³,Kritharis Athena¹,Feldman Tatyana⁴,Kroll Aimee⁵,Gascoyne Randy D.³,Abramson Jeremy S.⁶,Petrich Adam M.⁷,Hernandez-Ilizaliturri Francisco J.⁸,Al-Mansour Zeina⁹,Adeimy Camille¹⁰,Hemminger Jessica¹¹,Bartlett Nancy L.¹²,Mato Anthony⁴,Caimi Paolo F.¹³,Advani Ranjana H.¹⁴,Klein Andreas K.¹,Nabhan Chadi¹⁵,Smith Sonali M.¹⁵,Fabregas Jesus C.¹⁶,Lossos Izidore S.¹⁶,Press Oliver W.¹⁷,Fenske Timothy S.¹⁸,Friedberg Jonathan W.¹⁹,Vose Julie M.²⁰,Blum Kristie A.¹¹

Affiliation:

1. Tufts Medical Center; Boston Massachusetts

2. Johns Hopkins University School of Medicine; Baltimore Maryland

3. Centre for Lymphoid Cancer, British Columbia Cancer Agency; Vancouver BC Canada

4. Hackensack University Medical Center; Hackensack New Jersey

5. Quantitative Health Sciences, The University of Massachusetts (UMASS); Worcester Massachusetts

6. Massachusetts General Hospital Cancer Center; Boston Massachusetts

7. Northwestern University Feinberg School of Medicine; Chicago Illinois

8. Roswell Park Cancer Institute; Buffalo New York

9. Hematology/Oncology, UMASS; Massachusetts

10. Loyola University Medical Center; Maywood Illinois

11. Ohio State University; Columbus Ohio